Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) saw a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 2,190,000 shares, an increase of 16.5% from the April 30th total of 1,880,000 shares. Based on an average daily trading volume, of 167,500 shares, the short-interest […]
Wedbush reiterated their outperform rating on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Wedbush currently has a $41.00 price target on the stock. Other analysts also recently issued reports about the stock. Jefferies Financial Group initiated coverage on shares of Aerovate Therapeutics in […]
Wedbush restated their outperform rating on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research report report published on Wednesday, Benzinga reports. The brokerage currently has a $41.00 price target on the stock. AVTE has been the subject of a number of other reports. Wells Fargo & Company reissued an overweight rating and […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shares saw unusually-strong trading volume on Wednesday . Approximately 151,180 shares changed hands during trading, an increase of 15% from the previous session’s volume of 131,156 shares.The stock last traded at $20.38 and had previously closed at $19.28. Analysts Set New Price Targets Several research analysts have […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shares saw strong trading volume on Wednesday . 197,194 shares traded hands during trading, an increase of 52% from the previous session’s volume of 129,738 shares.The stock last traded at $22.91 and had previously closed at $23.22. Wall Street Analysts Forecast Growth A number of research analysts […]